1F. Di Raimondo,R. Giustolisi,S. Lerner,E. Cacciola,S. O’Brien,H. Kantarjian,M. J. Keating. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine[J] 2001,Annals of Oncology(5):621～625
同被引文献24
1Oscier D,Fegan C,Hillmen P. British Society of Hematology:guidelines on the diagnosis and management of chronic lymphocytic leukemia[J].British Journal of Haematology,2004,(03):293-317.doi:10.1111/j.1365-2141.2004.04898.x.
2Tobin G,Thunberg U,Laurel A. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome[J].HAEMATOLOGICA,2005,(04):465-469.
3Shanafelt TD,Geyer SM,Kay NE. Prognosis at diagnostics:integrating molecular biologic insights into clinical practice for patients with chronic lymphcytic leukemia[J].Blood,2004,(04):1202-1210.doi:10.1182/blood-2003-07-2281.
4Crespo M,Bosch F,Villamor N. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia[J].New England Journal of Medicine,2003,(18):1764-1775.doi:10.1056/NEJMoa023143.
6Laura Z,Rassenti P,Huynh L. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia[J].New England Journal of Medicine,2004,(09):893-901.doi:10.1056/NEJMoa040857.
7Orchard JA,Ibbotson RE,Davis Z. ZAP-70 expression and prognosis in chronic lymphocytic leukemia[J].LANCET,2004,(9403):105-111.
8Schroers R,Griesinger F,Tramper L. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia[J].Leukemia:Official Journal of the Leukemia Society of America Leukemia Research Fund U K,2005,(05):750-758.
9Joke BG,Lem KV,Langerak AW. CD38 as a prognostic factor in B cell chronic lymphocytic leukemia(B-CLL):comparison of three approaches to analyze its expression[J].Cytometry Part B(Clinical Cytometry),2006,(03):136-141.
10Hu HZ,New JY,Li B. Depletion of activated alloreactive T cells in prevention of acute graft-versus-host disease[J].Transplantation Proceedings,2000,(07):2456-2457.doi:10.1016/S0041-1345(00)01741-3.
